Sitagil M 100 mg+1000 mg (Tablet (Extended Release))
Unit Price: ৳ 35.00 (3 x 6: ৳ 630.00)
Strip Price: ৳ 210.00
Medicine Details
Category | Details |
---|---|
Generic | Sitagliptin metformin hydrochloride |
Company | Incepta pharmaceuticals ltd |
Also available as |
Indications
- Adjunct to diet and exercise for glycemic control in type 2 diabetes mellitus
- Not indicated for type 1 diabetes or diabetic ketoacidosis
- Not studied in patients with a history of pancreatitis
- Recommended limitations of use
Pharmacology
- Combines sitagliptin and metformin for glycemic control in type 2 diabetes
- Mechanisms of action of sitagliptin and metformin
- Incretin hormone regulation
- Glucose homeostasis regulation
- DPP-4 inhibitor
Dosage & Administration
- Individualized dosage based on patient's regimen
- Maximum recommended daily dose
- Twice-daily administration with meals
- Gradual dose escalation for reduced gastrointestinal side effects
- Recommended starting dose for patients not currently treated with metformin
- Starting dose in patients already treated with metformin
- Extended-release tablet dosage
Interaction
- Cationic drugs and renal tubular secretion
- Effect on phenprocoumon anticoagulant effect
- Levothyroxine interaction
- Interaction with insulin secretagogue or insulin
Contraindications
- Contraindicated in renal disease or dysfunction
- Acute or chronic metabolic acidosis
- History of serious hypersensitivity reaction
- Temporary discontinuation for radiologic studies involving contrast materials
Side Effects
- Common adverse reactions
- Adverse reactions in combination therapy
- Hypoglycemia
- Adverse reactions due to initiation of metformin therapy
Pregnancy & Lactation
- Pregnancy Category B
- Safety in pregnant women is not known
- Caution during nursing
Precautions & Warnings
- Risk of lactic acidosis
- Symptoms and laboratory abnormalities
- Long-term treatment associated with decrease in vitamin B12
- Hepatic disease precaution
- Assessment of renal function
- Monitoring for pancreatic complications
- Monitoring of hematologic parameters
- Caution against excessive alcohol intake
- Need for temporary insulin use during periods of stress
- Evaluation for evidence of ketoacidosis or lactic acidosis
- Macrovascular risk reduction
- Allergic and hypersensitivity reactions
Overdose Effects
- Supportive measures for sitagliptin overdose
- Dialyzable nature of sitagliptin
- Overdose of metformin hydrochloride
- Dialyzable clearance of metformin
- Pancreatitis in metformin overdose context
Therapeutic Class
- Combination oral hypoglycemic preparations
Storage Conditions
- Temperature and light storage conditions
- Safety and expiry precautions
Related Brands
- SB-Metsita 50 mg+500 mg (Tablet) - sunman-birdem-pharma-ltd
- SB-Metsita 50 mg+1000 mg (Tablet) - sunman-birdem-pharma-ltd
- Glucodip-M XR 50 mg+1000 mg (Tablet (Extended Release)) - sun-pharmaceutical-bangladesh-ltd
- Glucodip-M XR 50 mg+500 mg (Tablet (Extended Release)) - sun-pharmaceutical-bangladesh-ltd
- Radiglip-M 50 mg+500 mg (Tablet (Extended Release)) - radiant-pharmaceuticals-ltd